New Articles

Revolutionizing Healthcare: The Meteoric Rise of Smart Healthcare and Its Global Impact

smart healthcare HRSA

Revolutionizing Healthcare: The Meteoric Rise of Smart Healthcare and Its Global Impact

Introduction:

The healthcare landscape is undergoing a transformative journey, fueled by the integration of advanced technologies. The global smart healthcare market is on a trajectory of unprecedented growth, projected to reach an estimated USD 1,097.27 billion by 2032, with a staggering 18.5% Compound Annual Growth Rate (CAGR) from 2023-2032. At the heart of this revolution is the surging popularity of telemedicine, a testament to the paradigm shift from passive patient care to active participation empowered by technology.

From Passive Patients to Active Participants: Empowering Healthcare with Technology:

Smart healthcare harnesses cutting-edge technologies, including Artificial Intelligence (AI), the Internet of Things (IoT), and big data analytics, to enhance the quality and efficiency of healthcare services. Telemedicine, electronic health records (EHR), remote patient monitoring, and healthcare information exchange (HIE) are among the innovative solutions driving this sector forward. This shift is not just about improving patient outcomes but also about enhancing the overall healthcare experience and increasing operational efficiency in healthcare organizations.

Telemedicine: Bridging Healthcare Gaps Virtually:

Telemedicine, or telehealth, stands as a frontrunner in the smart healthcare revolution. Allowing healthcare professionals to diagnose and treat patients remotely, telemedicine has become indispensable, particularly in regions facing a shortage of healthcare professionals. As of 2022, it held the lion’s share in the smart healthcare market, contributing to 37.27% of the revenue and is projected to grow at a remarkable CAGR of 12.3% from 2023 to 2032.

The Impact of Telemedicine:

The adoption of telemedicine is propelled by factors such as the scarcity of healthcare professionals, the need for remote monitoring of chronic patients, and the growing demand for virtual consultations. Telemedicine’s significance was further underscored during the COVID-19 pandemic, proving its capability to provide medical care without physical visits to healthcare facilities.

Smart Healthcare Goes Global: Europe and Asia Pacific Leading the Charge:

The global adoption of smart healthcare is not uniform, with Europe and Asia Pacific leading the charge. Europe, accounting for 33.04% revenue share in 2022, is expected to maintain a substantial position with a CAGR of 10.8% from 2023 to 2032. Asia Pacific, projected to register the fastest growth at a CAGR of 13.0% (2023-2032), is embracing smart healthcare due to increasing demand, investments in healthcare infrastructure, and rising chronic diseases.

RPM and Smart Healthcare: Transforming Patient Care:

Remote Patient Monitoring (RPM) is emerging as a game-changer in healthcare, allowing continuous monitoring and care outside traditional healthcare settings. Integrated with wearables and mobile apps, RPM enables early intervention, personalized care, and reduced hospital readmissions. With an aging population and a surge in chronic diseases, RPM is crucial for managing complex medical needs.

Convergence of Self-care, Wellness, and Smart Healthcare:

The convergence of self-care, wellness, and smart healthcare is reshaping the healthcare landscape. Smart healthcare technologies, integrated with wearables and mobile apps, empower individuals to take control of their health. This proactive approach is vital in preventing illnesses, fostering better health outcomes, and reducing healthcare costs in the long run.

Data Defence: Addressing Privacy and Security Challenges:

As smart healthcare relies on sensitive patient data, data security and privacy are paramount. Robust security measures, compliance with regulations like HIPAA and GDPR, regular security audits, and education for patients and employees are essential. Blockchain technology is also being explored to ensure a decentralized, tamper-proof record of patient data.

App-Based PERS: Redefining Emergency Response Systems:

App-based Personal Emergency Response Systems (PERS) are revolutionizing emergency response by providing individuals with immediate access to services via smartphones. Affordable and feature-rich, app-based PERS offer more than just emergency response, incorporating medication reminders, fall detection, and activity tracking. However, challenges such as dependence on reliable internet connectivity and potential privacy concerns should be addressed.

Conclusion:

The smart healthcare revolution is reshaping the healthcare landscape, offering a future where technology empowers individuals to actively participate in their well-being. From the virtual embrace of telemedicine to the transformative potential of RPM and the convergence of self-care and wellness, smart healthcare is a beacon of progress. As we navigate the data security challenges and embrace innovative solutions like app-based PERS, the global impact of smart healthcare is poised to create a healthier, more connected world. With Europe and Asia Pacific leading the way, the journey from passive patients to active participants in healthcare has just begun. The next decade promises to be a remarkable era of technological advancements, improved healthcare outcomes, and a global community taking charge of its well-being.

Report Source: https://www.towardshealthcare.com/insights/smart-healthcare-market-new-technology-meets-medicine

UV LED plastic

FMI’ Analyst view: “Innovative Packaging for Lifesaving Solutions: Plastic Healthcare’s Eco-Advancements”

The plastic healthcare packaging market is estimated to be valued at US$ 24,768.7 million in 2023 to reach an expected valuation of US$ 40,306.8 million by 2033. The demand for plastic healthcare packaging is projected to record a CAGR of 5% during the forecast period.

The healthcare industry is rapidly growing, and with it, the demand for high-quality packaging solutions. Plastic healthcare packaging is increasingly being preferred by manufacturers due to its durability, affordability, and versatility. The rise in demand for medical supplies and medicines has boosted the growth of the plastic healthcare packaging market.

Manufacturers are focusing on developing innovative packaging solutions to meet the diverse needs of their customers. They are experimenting with various shapes, colors, and designs to attract consumers and improve product visibility. Packaging solutions with advanced features, such as tamper-evident seals and child-resistant closures, are becoming popular among consumers.

Rising Demand for Child-Resistant Packaging

As the global population ages, the demand for medication and other healthcare products is increasing, leading to a growing demand for child-resistant packaging. This is especially important for products that pose a risk to children, such as medications and medical devices. Plastic healthcare packaging manufacturers are investing in new technologies to develop child-resistant packaging that is safe, durable, and easy to use.

Technological advancements in packaging design are helping to improve the functionality and safety of plastic healthcare packaging. For example, smart packaging solutions can improve product shelf life, reduce waste, and help consumers make informed purchasing decisions. In addition, advanced packaging design technologies are enabling manufacturers to produce lightweight, cost-effective, and easy-to-use packaging solutions that meet the needs of the healthcare industry.

Challenges Faced by the Plastic Healthcare Packaging Manufacturers

Despite the growth of the plastic healthcare packaging market, several challenges remain that players must overcome to continue their success. One of the major challenges is the increasing pressure from environmental groups and consumers for more sustainable packaging solutions. Plastic packaging has a significant environmental impact, and as consumers become more environmentally conscious, the demand for more sustainable packaging options is increasing.

Another challenge faced by players in the plastic healthcare packaging market is the need for specialized materials and designs to accommodate the specific requirements of different healthcare products. The materials used in healthcare packaging must be safe, effective, and meet strict regulatory standards. This requires a high level of expertise and investment, which can be a barrier to entry into the market for some players.

Companies are looking for ways to minimize packaging waste and increase efficiency, which is putting pressure on players to improve their operations and reduce the impact of their packaging on the environment. Companies must find ways to balance these concerns with the need to protect and preserve their healthcare products, making it a challenging market to navigate.

Country-wise Insights

Why is the United States Estimated to be a Highly Lucrative Plastic Healthcare Packaging Market?

The United States plastic healthcare packaging industry was estimated to be worth US$ 4,648.1 million in 2022. The United States is currently the most attractive market, according to FMI. The United States is estimated to hold a market share of 19.5% in North America and is estimated to have a year-on-year growth rate of 5% in 2023.

The United States remains one of the leading manufacturers of pharmaceutical drugs, directly increasing the demand for safe and high-quality healthcare packaging.

According to the Organization for Economic Co-operation and Development (OECD), the United States is globally the country with the highest per capita healthcare spending, totaling US$ 10,966 Mn in the year 2019. The United States also spends more per person on health care and medicines than any other country.

Why is the Demand for Plastic Healthcare Packaging Increasing across China?

China plastic healthcare packaging industry is anticipated to rise at a CAGR of 8.8% during the forecast period. The China plastic healthcare packaging industry is estimated to be worth US$ 3,125.7 million in 2022. As per PlasticsEurope, a European trade association, world plastic production was nearly 368 million tons in 2019 and China accounted for more than 1/3rd of the volume share.

Amid the COVID pandemic, the government in China has boosted the production of plastic healthcare packaging solutions. The availability of plastic raw materials is propelling growth opportunities for the key players of the target market.

China is one of Asia’s largest contributors to the production of healthcare products. The enormous market continues to grow rapidly driven by economic growth, expenditure, and an aging population owing to investments in basic health treatments. The country is projected to grow rapidly due to the low cost of raw materials and labor charges.

Why are Market Players Willing to Invest in India?

India plastic healthcare packaging industry was worth US$ 1,794.4 million in 2022. Increasing government initiatives and awareness regarding personal health and hygiene are key factors supporting demand. The country is expected to witness prominent growth of 8.6% during the assessment period.

According to FMI, the Indian market is growing steadily due to the presence of several small-and-large scale companies that are ready to widen their reach for the production of plastic healthcare packaging.

This growth is attributable to economic development, low cost of labor, and deployment. Many key players are looking to invest in multiple profit-earning opportunities in the emerging economies of India and China.

Why are Manufacturers Eyeing Germany to consolidate their Market Position?

In 2022, Germany accounted for a 4.6% share of the global plastic healthcare packaging industry. The German plastic healthcare packaging industry is estimated to be worth US$ 1,083.9 million in 2022.

The Federal Statistical Office of Germany has reported that healthcare spending rose by 4% in 2018 from 2017 in Germany. In 2018, the country’s healthcare expenditure accounted for 11.7% of the GDP. Moreover, the country’s projected healthcare spending exceeds US$ 505 Bn in 2020, creating a conducive environment for the expansion of the plastic healthcare packaging industry.

Demand for plastic healthcare packaging in Germany is expected to rise at nearly 3.8% CAGR over the forecast period. Germany is well known for its technology-driven industry and its developments in the healthcare sector owing to the stringent government rules and initiatives. The rise in several factories of medical devices and high consumer attractiveness towards healthcare is anticipated to cover over 4.6% of the Europe market by the year 2033.

Competitive Landscape

Companies operating in the plastic healthcare packaging industry are aiming for strategic collaborations and partnerships with other manufacturers to expand their product portfolio, in addition to investing in capacity expansions.

·         In April 2021, Amcor plc launched a recyclable polyethylene-based thermoform blister packaging format. It is intended to meet the high standards of regulated pharmaceutical packaging that creates a sustainable alternative.

·         In January 2021, Gerresheimer planned to build a second production plant near Mumbai, India to meet plastic healthcare packaging requirements worldwide. The product portfolio includes plastic containers, plastic ampoules, plastic bottles, and more in a variety of designs.

·         In December 2020, Airnov Healthcare Packaging introduced OXYNOV. The packaging products are applicable for high protective barrier bottles required for pharmaceutical, nutraceutical, and probiotic products.

How Route Optimization Benefits the Pharmaceutical Industry?

How Route Optimization Benefits the Pharmaceutical Industry?

The timely transportation of lifesaving drugs is detrimental to the pharmaceutical industry’s success. Pharma companies work on clinical trials and advanced research that requires drug delivery and storage options. Even the slightest mistake during the logistics process may seriously delay the delivery and impact both Pharma companies and their customers. On top of that, pharmaceutical companies are currently struggling with the logistics process. As the most crucial element, Last-mile delivery services are impacted due to a multitude of factors. It seems that the most efficient solution to this problem is route optimization. Here is how route optimization benefits the pharmaceutical industry and potentially may solve all major issues.

Last-mile delivery services complexities and problems

There is an array of global logistics issues for the Pharma industry. The most common ones include the following:

  • supplying cold-chain Pharma products;
  • non-refrigerated supplies;
  • safety guidelines for geographically varying distribution;
  • truck capacity limitations;
  • the global shortage of drivers;
  • increased needs for special storage requirements;
  • complex emergency security measures;
  • the change in temperature;
  • no visibility over the logistics processes;
  • difficulties regarding sudden On-Demand deliveries;
  • unpredictable traffic jams;

These are just some of the issues that happen during the last mile delivery services. With that in mind, here is how route optimization may contribute to Pharma companies and solve these issues on a global scale.

Plan flexible delivery schedules

When delivering drugs to Pharma companies and various establishments, one of the most valued resources is time. Shipment must be delivered without delays because that creates a lack of trust. Any issues with the delivery usually happen because there is no flexibility in planning the traditional routes.

Some Pharma companies, like nursing homes, require emergency deliveries, which is where flexible route planning comes into place. It is essential to prioritize and always deliver shipments with higher priority first.

Deliveries of pharma shipments involve many costs due to various shipment needs. As mentioned, some shipments require refrigerated trucks, special storage units, temperature control, and increased driver awareness. On top of that, commercial warehousing costs also come into place. Failure to accommodate these conditions might lead to discarding medical supplies worth a lot of money.

End-to-end technology plays an essential role here because it allows full visibility of the route planning process. That is the best approach to avoid these problematic situations due to non-flexible route planning. With the right technology system in place, you will have real-time status on all vehicles, allowing more control over fleet management and operations.

Route optimization reduces wasteful transportation costs

Over 80% of different types of drugs and 90% of vaccines require temperature-controlled storage during the delivery process. Many costs are involved in maintaining such a complex shipment delivery. Last-mile delivery managers and drivers hold a great responsibility for delivering these products.

If we compare that type of delivery with common goods, we can notice a difference in the price of delivery. Transportation trucks for the pharma industry require controlled room temperature systems, refrigerants, insulated containers, thermal blanketing, and various devices for monitoring temperature. That is why traveling from the storage to the customer needs to happen fast. Otherwise, the companies will lose money on failed shipments and discarded medical products.

Sudden on-demand deliveries benefit from cost-efficient route planning with route optimization software. The system will auto-adjust routes in an emergency and ensure timely delivery to reduce wasteful transportation costs. Furthermore, it also tracks transportation costs, giving you full visibility of your expenses.

Workload distribution is essentials

Another common issue in the pharma industry is uneven workload distribution between multiple trucks. When an urgent delivery happens, a truck must be quickly packed and sent to the delivery address. In case of a poor planning process, the truck will go half empty, while others might be overpacked. This will seriously affect transportation expenses due to fuel costs and potential maintenance issues with trucks.

Furthermore, when planning delivery routes for the entire fleet, the lack of visibility in the workload distribution process might cause additional expenses. All trucks must have proper workload distribution to ensure timely delivery to all locations.

Another reason for this issue is the shortage of experienced delivery staff. Whether we are talking about the drivers or delivery planning managers, this represents a serious issue in logistics. Limited driver capacity must have an unlimited number of requests.

Moreover, not all trucks are suitable for deliveries that require temperature control. If all trucks with the temperature-control system are on delivery, other shipments will have to wait until a truck is free. Routine optimization software can solve these complexities because it ensures even workload distribution. It automatically assigns work and calculates the routes based on driver shortage, traffic conditions, outside temperature, truck capacity, various risk zones, and so on.

The system provides optimized routes in such a way that they do not involve additional costs or any human error. Furthermore, if the plan of the route changes, the system quickly recalculates the next best route.

Route optimization benefits the pharmaceutical industry in many ways

The entire pharma industry depends on the transportation and distribution processes. Advanced technology for route optimization benefits the pharmaceutical industry and ensures on-time urgent deliveries. Furthermore, it reduces unnecessary labor, fuel, and visibility costs and maintains the quality of the last-mile delivery services. The entire future of the pharma industry dramatically depends on route planning and route optimization software.

Author bio

Lester Martens is a professional blogger and content creator for Bright Futures Treatment Center. He has a huge passion for researching advanced system technologies and project management. Lester aims to help both small and large businesses to ensure the quality of service.

nebraskans

NEBRASKANS SUPPORT TRADE BUT TRUST IN MEDIA AND WASHINGTON IS LOW

A new survey of Nebraskans finds that citizens appreciate trade’s benefits, especially for farmers and ranchers, but want more reliable information about trade policy.

Anxious but confident: the more international trade the better

Nebraskans surveyed are anxious about the economy but confident with respect to the importance of trade to their state’s agricultural production complex.

Released last month by the Carnegie Endowment for International Peace and the University of Nebraska-Lincoln (UNL), the new report, “U.S. Foreign Policy for the Middle Class: Perspectives from Nebraska,” assesses state views about how U.S. foreign policy interacts with the economic wellbeing of the middle class in the nation’s heartland. The research team interviewed over 130 Nebraskans in six communities across the state in the summer of 2019 (before the economy was further affected by the coronavirus pandemic) to gauge their perceptions.

Whether respondents hailed from urban Omaha or rural Scottsbluff, and whether they worked directly in agriculture or in health care, local government or education, those interviewed were remarkably consistent and clear on the subject of trade policy and the state’s agriculture sector: the more international trade, the better.

Focus Group Cities

The big picture is not the only picture in the Nebraska economy

Macro-level statistics obscure the importance of Nebraska’s agriculture sector. The Bureau of Labor Statistics reports that manufacturing contributes more than twice as much as agriculture to Nebraska’s GDP (10.9 percent versus 4.9 percent, respectively). But within manufacturing, “food and kindred products” is the top category. The broader agricultural production complex includes processing but also transportation, warehousing, agriculture-related research, and other professional services such as IT, legal, insurance, and financial.

Thus, while Nebraska has a diversified economy and workforce, one in four jobs is directly or indirectly tied to the state’s agricultural production complex, according to UNL researchers. Some interviewees pointed to main street businesses like car dealerships as a barometer for agriculture, saying that farmers are more likely to purchase new cars or trucks when they have profitable years.

As the report notes, “Even if they do not hold one of those ag-related jobs, most Nebraskans likely benefit in some way from the revenues the sector generates. That may explain why so many of those interviewed, whether directly involved with agriculture or not, said they supported any trade policies that worked best for farmers, ranchers, and others associated with the agricultural production complex.”

Trade a most important foreign policy

Exports dominate the discourse on trade

The Nebraskans interviewed spoke about trade almost exclusively in terms of exports, perhaps not surprising for a state that consistently ranks highly in the production and export of many agricultural products from soybeans and corn to beef and beef products. Nebraska’s most important export markets are Canada and Mexico, U.S. free trade agreement partners.

The majority of those interviewed saw U.S. trade agreements as benefiting Nebraskan agriculture, in particular the U.S.-Mexico-Canada Agreement (USMCA) and the U.S. trade deal with Japan (as a second best alternative to the Transpacific Partnership, from which the U.S. withdrew in 2017). While many supported the President’s tough stance against China, they also worried about the potential for future lost market share due to shifting supply chains brought on by the trade war. In the voice of one interviewee, over the long run, the United States needs to “focus [more] on developing markets…and less…on picking a fight with China.”

The seeming invisibility of imports

Imports were rarely mentioned by those interviewed, whether from a consumer or supply chain perspective. Aside from one manufacturer who said that increased steel tariffs had put cost pressure on his inputs, most discussion of tariffs revolved instead around retaliation on U.S. agriculture exports, not the impact of U.S. tariffs on imports. This is not surprising: exports are celebrated in news releases and headlines. Import data is portrayed in the negative light of trade imbalances. Imports of intermediate goods make up 60 percent of global trade by some estimates, but in the form of parts and components for the production of final goods, they lack visibility.

U.S. import tariffs have likely affected consumer prices to some degree. In research prepared for the Yeutter Institute by Edward Balistreri of Iowa State University, tariffs imposed in 2018 and 2019 as part of the U.S.-China trade war may have cost Nebraska’s households as much as $600 per year through a combination of lost export opportunities, increased productions costs, and increased consumer prices. A potential doubling of tariff costs on imported items theoretically risked households near the lower bounds of the middle-income range falling out of the middle-income bracket while those tariffs were in place. Despite being a pocketbook issue, the cost of imports was notably absent as a topic of discussion across interviews.

View on China engagement

There is more than one “heartland”

The Carnegie Endowment conducted similar interviews and focus groups in Ohio in 2018 and Colorado in 2019. There are important nuances among and within these three states. On trade policy, Nebraskans were far more aligned in their views than Ohioans.

Nebraskans tend to view agriculture as the backbone of the state’s economy, leading to more consistent opinions on the beneficial role of trade. Ohio has a much larger manufacturing workforce that has experienced heavy losses in recent years, with trade policy and globalization often taking the blame. This perception has led to deep divisions over trade policy among those interviewed in Ohio.

In comparing the three states, the report notes that such “place-based economic considerations appeared to drive attitudes on the intersection of U.S. foreign policy with the perceived economic interests of America’s middle class.”

“I don’t trust Washington”

Unfortunately, where participants in all three states did seem to agree was in their mistrust of institutions and their sources of information regarding foreign policy.

Project participants consistently said they did not trust the news media or official Washington to provide unbiased information about trade and foreign policy. As a result, many said they do not always feel they have enough knowledge to develop well-informed opinions. They also do not believe that decisions about foreign policy are made with middle America’s economic interests in mind.

One Nebraska participant illustrated a common sentiment in expressing, “I don’t think anybody knows what the truth is and I don’t …trust Washington to tell me what the truth is.” If participants wanted to learn more about trade and foreign policy, they often said they did not know where to find trustworthy sources of information.

Quote about trust

How to amplify middle-class voices?

At a time of intense debate over what the aims of U.S. trade policy should be, such depth of perspective from Americans across the country is important. Do we need new structures to gather it?

The Office of the U.S. Trade Representative formally seeks public comment as part of its process to determine negotiating priorities and statutorily maintains 26 advisory committees to make sure U.S. negotiating objectives “reflect U.S. public and private sector interests.” The advisory system includes a committee designed for input from state and local level leaders. Yet these structures are neither visible nor accessible to most Americans.

Elected officials may of course offer input outside of these constructs. Nebraska Governor Pete Ricketts gave an example on an episode of the Yeutter Institute’s Trade Matters podcast:

“When there was a rumor that the United States was going to pull out of the South Korean Trade Agreement, I picked up the phone on a Friday afternoon to call our U.S. Trade Representative, Ambassador Lighthizer, to tell him how bad that would be for Nebraska,” Governor Ricketts said.

“He called me back on Sunday afternoon, so very responsive…he doesn’t always tell you what you want to hear, but certainly wanted to listen as I was talking about why South Korea was such an important trading partner.”

Place-based trade policies?

Governor Ricketts’ comments and the report findings reinforce a central conundrum of trade policy: it has disparate impacts on the economies of different U.S. states.

In their pursuit of the national interest, foreign policy professionals, including trade negotiators, understandably do not want to pick winners and losers or wade into domestic politics. But integrating more information about the economic experience of middle-class Americans into the trade policymaking process can help inform policy options that anticipate the losses — and local opportunities — from trade policy.

Meanwhile, what about those who said they wanted to learn more about trade and foreign policy, but did not know where to find information they could trust? They also reported that locally trusted leaders can play a key role in how people think about policies. Perhaps such leaders are a starting point for deeper conversations about trade.

Related in the series by The Carnegie Endowment on U.S. Foreign Policy for the Middle Class:

-Perspectives from Colorado

-Perspectives from Ohio

___________________________________________________________

Jill O'Donnell

Jill O’Donnell is a professor of practice and the director of the Clayton Yeutter Institute of International Trade and Finance at the University of Nebraska-Lincoln. She is the host of the institute’s Trade Matters podcast. She served on the research team for the report discussed in this article, along with colleagues from the University of Nebraska-Lincoln’s Bureau of Business Research and the University of Nebraska Public Policy Center, in partnership with the Carnegie Endowment for International Peace.

This article originally appeared on TradeVistas.org. Republished with permission.